Has Ali Siddiqui, MD received payments from drug or device companies?

Yes. Drug and device makers reported $166,738 in general payments to Ali Siddiqui, MD across 382 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ali Siddiqui, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ali Siddiqui, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ali Siddiqui, MD

Gastroenterology · Fairfax, VANPI 1265478275

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $123,050 of the $166,738 with a category attached, or 73.8%. AbbVie accounts for 89.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $40,679 and has fallen 95.9% since, to $1,650 in 2025. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$166,738in general payments, 2019–2025

Across 382 payments — averaging $436.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$149K
Boston Scientific$5K
Olympus America Inc.$2K
Olympus Corporation Of The Americas$2K
Apollo Endosurgery US Inc$1K
Merck$1K
plus $6K from 21 others

What the payments were for

Consulting fees$1,6401%
Speaking & faculty fees$123,05074%
Travel & lodging$24,36915%
Food & beverage$17,68011%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	147	$148,680
Boston Scientific	92	$4,909
Olympus America Inc.	27	$2,360
Olympus Corporation Of The Americas	21	$1,675
Apollo Endosurgery US Inc	12	$1,338
Merck	2	$1,290
Conmed Corporation	23	$1,280
Cook Medical LLC	18	$1,012
Fujifilm Healthcare Americas Corporation	5	$638
Medtronic	8	$439
Steris Corporation	2	$393
Ambu Inc.	3	$390
Merit Medical Systems Inc	2	$365
Endogastric Solutions, Inc	3	$245
Covidien LP	2	$233
Gilead	2	$232
Johnson & Johnson	1	$150
Pentax Of America, Inc.	2	$147
Madrigal Pharmaceuticals	1	$143
Enterra Medical, Inc.	2	$140
E.r. Squibb & Sons, L.L.C.	1	$125
Pfizer	1	$125
Aroa Biosurgery Incorporated	1	$116
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$116
Teva Pharmaceuticals USA, Inc.	1	$103
ERBE USA Inc	1	$79
Takeda Pharmaceuticals U.S.A., Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Creon$74,087
Single Use Electrosurgical Knife KD-655$1,333
OverStitch Endoscopic Suturing System$1,028
EXALT Model D$1,004
DISPOSABLE DISTAL ATTACHMENT$909
CONMED BILIARY$830
AXIOS$603
FUJIFILM$545
LINZESS$471
Single Use Electrosurgical Hemostatic Forceps$425
EndoClot PHS$410
TRUFREEZE$393
VISIGLIDE$374
Transmaxx$350
Beacon$310
HANAROSTENT LowAxTM Duodenum/Pylorus(NNN)$297
GENERAL - METAL STENTS - G.I.$292
GENERAL - THERAPIES$262
X-Tack Endoscopic HeliX Tacking System$261
RESOLUTION CLIP$235

How this compares

$166,738 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.

See all gastroenterology providers in Virginia →

Medicare billing

Part B allowed, 2024

$84,659

Medicare patients

208

Services billed

431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	17	$204
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	11	$179

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Fairfax

Michael GaroneFairfax$64K
Asma KhapraFairfax$49K
Jeremias TanFairfax$18K
Richard BlosserFairfax$14K
Tonya AdamsFairfax$13K
Larry ClarkLynchburg$1.2M
Arun SanyalRichmond$855K
Mitchell ShiffmanNewport News$635K
Bryan SauerCharlottesville$540K
Michael RyanNorfolk$335K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →